Skip to main content
Microbiology Spectrum logoLink to Microbiology Spectrum
. 2026 Jun 23;14(8):e01130-26. doi: 10.1128/spectrum.01130-26

Emergence of Acinetobacter soli harboring three carbapenemase-encoding genes (blaNDM-1, blaIMP-14, and blaOXA-58) on a single plasmid in an ICU patient

Qiao Li 1,#, Nanqi Zhang 1,#, Hao Guo 1,#, Juan Xu 2, Andrey Bakunovich 3, Wenping Lin 4,✉, Fang He 1,✉
Editor: Mehrad Hamidian5
PMCID: PMC13435676  PMID: 42334215

ABSTRACT

Acinetobacter soli is an environmentally adaptable species increasingly recognized as an emerging pathogen in hospital settings, particularly in intensive care units (ICUs). In this study, we report the first A. soli isolate from an ICU patient that co-harbors three carbapenemase-encoding genes (blaNDM-1, blaIMP-14, and blaOXA-58) on a single plasmid. Whole-genome sequencing revealed that multidrug resistance in this strain is mediated by a 294,790 bp plasmid, pSLAB-A, carrying 16 antimicrobial resistance genes, including all three carbapenemases. Comparative plasmid analysis showed a highly conserved backbone but identified a unique ~40 kb multidrug-resistance region containing blaNDM-1, blaIMP-14, and eight additional resistance genes. Genetic context analysis indicated that insertion sequences (ISAba125 and ISAba3) and class 1 integrons contribute to the mobilization and accumulation of carbapenemase-encoding genes. Plasmid stability assays demonstrated that pSLAB-A remained stably maintained for more than 90 generations without antibiotic selection. A global survey of the NCBI database identified 15 A. soli strains carrying carbapenemase-encoding genes, most of which were isolated from China, with clinical specimens representing the predominant source. Seven carbapenemase-encoding genes were detected, with blaNDM-1 being the most prevalent. Among eight isolates with complete genomes, all carried carbapenemase-encoding genes on plasmids. Phylogenetic analysis revealed regional dissemination of a clonal lineage across hospitals in Zhejiang Province and sustained nosocomial transmission within a hospital in Taiwan. These findings suggest that the spread of carbapenem resistance in A. soli is largely driven by multidrug-resistance plasmids, facilitating clonal expansion in hospital environments and posing a growing challenge for antimicrobial therapy and infection control in ICUs.

IMPORTANCE

Carbapenem-resistant A. soli is an emerging clinical concern, capable of causing severe invasive infections, including bacteremia, in intensive care unit settings, and its emergence poses substantial challenges to antimicrobial therapy. In this study, we demonstrate that carbapenem resistance in A. soli is predominantly mediated by the acquisition of multidrug-resistance plasmids carrying carbapenemase-encoding genes. Owing to its strong environmental persistence, A. soli can readily undergo nosocomial clonal dissemination once carbapenem resistance is acquired. Moreover, the spread of multidrug plasmids co-harboring multiple carbapenemase-encoding genes may accelerate the evolutionary trajectory of resistance in A. soli, further exacerbating the threat to clinical management. Given its demonstrated capacity to cause hospital-associated infections and to rapidly acquire multidrug resistance, A. soli warrants heightened vigilance from both clinical and public health perspectives.

KEYWORDS: Acinetobacter soli, carbapenemase, bla OXA-58 , bla NDM-1 , bla IMP-14

INTRODUCTION

The genus Acinetobacter comprises pleomorphic gram-negative coccobacilli and is a well-recognized cause of healthcare-associated infections, particularly in intensive care units (ICUs). Infections caused by Acinetobacter spp. include ventilator-associated pneumonia, bloodstream infections, and urinary tract infections, imposing a substantial burden in hospital settings (1–4). Acinetobacter soli, an environmentally adaptable member of this genus, was first identified in 2008 from forest soil in South Korea (5). Since then, its clinical relevance has become increasingly evident. In 2011, an outbreak of clonally related A. soli isolates causing bloodstream infections in a neonatal ICU (involving five neonates) was reported (6). The first carbapenem-resistant A. soli isolate in China was described in 2014, recovered from a patient with ICU-associated bloodstream infection (7). More recently, in 2023, carbapenem-resistant A. soli strains isolated from patients with bacteremia were reported in Japan (8). These findings indicate that A. soli is capable of causing severe infections in ICU settings and may represent an emerging clinical threat.

According to 2024 data from the China Antimicrobial Resistance Surveillance System (CHINET), resistance rates of Acinetobacter spp. to the carbapenems meropenem and imipenem reached 64.7% and 64.5%, respectively (9). The global emergence of carbapenem-resistant Acinetobacter has therefore severely restricted available therapeutic options (10, 11). Carbapenem resistance in Acinetobacter spp. is primarily mediated by the production of carbapenemases that hydrolyse carbapenems (12, 13). Based on the Ambler classification, β-lactamases are divided into four molecular classes (A–D), of which classes A, C, and D are serine β-lactamases, whereas class B comprises metallo-β-lactamases; carbapenemases are mainly distributed among classes A, B, and D (14, 15).

In this study, we identified a carbapenem-resistant A. soli strain SLAB, isolated from a male patient with a urinary tract infection, which co-harbored three carbapenemase-encoding genes, blaNDM-1, blaIMP-14, and blaOXA-58. Whole-genome sequencing and bioinformatic analyses were conducted to characterize its genomic features, with particular emphasis on the genetic contexts, chromosomal or plasmid localization, and potential transmission mechanisms of these carbapenemase-encoding genes. Furthermore, we searched the NCBI database and performed a global epidemiological analysis of all available carbapenemase-producing A. soli strains.

MATERIALS AND METHODS

Patient and isolate

The A. soli strain SLAB was isolated in 2019 from a urine sample of a male patient admitted to the intensive care unit of a tertiary hospital in Hangzhou, China. The patient was initially admitted to the Department of Hematology with a diagnosis of myelodysplastic syndrome and underwent hematopoietic stem cell transplantation. On hospital day 117, he developed progressive dyspnea and worsening pulmonary inflammation, necessitating endotracheal intubation and transfer to the ICU. A. soli was isolated from the urine sample 2 days after ICU admission. The isolate exhibited heavy growth with no mixed flora, indicating a pure culture. Notably, the patient did not have an indwelling urinary catheter, suggesting that the infection was unlikely to be catheter associated. Species identification was initially performed using the VITEK MS system (bioMérieux, France) and subsequently confirmed by whole-genome sequencing, with species assignment validated through comparison with reference genomes using the JSpeciesWS platform.

Antimicrobial susceptibility test

Antimicrobial susceptibility testing of strain SLAB was performed using the VITEK 2 system with the AST-GN13 card and the standard broth microdilution method, in accordance with the Clinical and Laboratory Standards Institute (CLSI) guidelines (CLSI M100, 34th edition). The antimicrobial agents tested included ampicillin/sulbactam, ceftriaxone, ceftazidime, cefepime, imipenem, meropenem, tobramycin, gentamicin, levofloxacin, ciprofloxacin, trimethoprim–sulfamethoxazole, and tigecycline. Susceptibility interpretations were based on CLSI-defined breakpoints, except for tigecycline, for which the U.S. Food and Drug Administration criteria were applied.

Whole-genome sequencing

Genomic DNA was extracted using the QIAamp DNA Mini Kit (Qiagen, USA). Whole-genome sequencing was performed using the Illumina NovaSeq 6000 platform (Illumina Inc., San Diego, CA, USA) and the Oxford Nanopore MinION sequencer (Oxford Nanopore Technologies, Oxford, UK). Illumina sequencing was conducted in 150 bp paired-end mode, achieving an average coverage depth of ≥100×, while Nanopore sequencing yielded an average coverage depth of ≥50×. Hybrid de novo assembly was carried out using Unicycler v0.5.0, followed by genome annotation with the NCBI Prokaryotic Genome Annotation Pipeline (PGAP).

Bioinformatics analysis

Antibiotic resistance genes were identified using ABRicate v0.8.10 with the ResFinder database, applying thresholds of ≥90% identity and ≥90% coverage for resistance gene identification (16). Insertion sequences (ISs) on plasmids were predicted using ISfinder (17). Plasmid conjugative transfer ability was predicted using VRprofile2 (18). The genetic contexts of blaNDM-1 among different plasmids were compared using EasyFig v2.2.3 (19). Plasmids showing similarity to the carbapenemase gene-carrying plasmid identified in strain SLAB (pSLAB-A) were retrieved from the NCBI database. Circular comparative analyses of carbapenem resistance gene-bearing plasmids were performed using the BLAST Ring Image Generator v0.95, with results visualized as concentric ring maps (20). Plasmid replicon typing was performed using the Acinetobacter Plasmid Typing (APT) database version 3.0.0. Replication initiation (rep) gene sequences were clustered at a 95% nucleotide identity threshold, and representative Rep/rep sequences from the database were used for type assignment (21, 22).

Phylogenetic analysis

To investigate the global epidemiology of carbapenem-resistant Acinetobacter soli, we searched the NCBI GenBank database using the keyword “Acinetobacter soli” (accessed October 2025) and retrieved all publicly available genome assemblies. Only entries annotated as “genome assembly” with downloadable FASTA files were included. Both complete and draft genomes were retained without exclusion based on assembly level to maximize data set coverage. A total of 84 A. soli genomes were identified worldwide, among which 15 carried carbapenemase-encoding genes. These 15 isolates were subjected to phylogenetic analysis using Snippy v4.6.0 for core-genome single-nucleotide polymorphism (SNP) calling and FastTree v2.1.11 for tree construction. The resulting phylogenetic tree was visualized using iTOL v7 (https://itol.embl.de).

Conjugation experiments

The transferability of plasmid pSLAB-A was evaluated using a filter-mating conjugation assay, with rifampicin-resistant A. baumannii ATCC 17978 serving as the recipient strain (23). Transconjugants were selected on Mueller-Hinton (MH) agar plates supplemented with rifampicin (100 μg/mL) and meropenem (4 μg/mL). The identity of the transconjugants was further confirmed by PCR amplification followed by Sanger sequencing.

Stability of the carbapenemase gene-carrying plasmid

The stability of the carbapenemase gene-carrying plasmid in A. soli was evaluated by serial passaging in the absence of antibiotic pressure. Briefly, a single colony of A. soli SLAB was inoculated into 3 mL of LB broth and incubated at 37°C with shaking for 24 h. Each day, 3 μL of the overnight culture was transferred into fresh LB broth at a 1:1,000 dilution. Under this dilution scheme, the culture increased from approximately 106–109 CFU/mL per day, corresponding to ~10 bacterial generations daily. This procedure was repeated for 9 consecutive days (approximately 90 generations). Every 3 days, cultures were serially diluted with sterile phosphate-buffered saline and plated onto MH agar without antibiotics, followed by overnight incubation at 37°C. Forty colonies were randomly selected from each time point, and the presence of blaNDM-1, blaIMP-14, and blaOXA-58 was determined by PCR. The proportion of colonies harboring all three genes among the 40 screened colonies was calculated to assess plasmid stability (24).

RESULTS AND DISCUSSION

The minimum inhibitory concentrations of antimicrobial agents against A. soli strain SLAB are summarized in Table S1. Antimicrobial susceptibility testing showed that SLAB was resistant to ampicillin/sulbactam, ceftriaxone, ceftazidime, cefepime, imipenem, and meropenem; exhibited intermediate susceptibility to tobramycin and gentamicin; and remained susceptible to ciprofloxacin, levofloxacin, trimethoprim–sulfamethoxazole, and tigecycline.

The assembled genome of strain SLAB comprised seven contigs with a total length of 3,876,811 bp, including a circular chromosome of 3,459,198 bp and six circular plasmids of 294,790 bp, 97,614 bp, 12,013 bp, 5,480 bp, 4,868 bp, and 2,848 bp, respectively. PGAP annotation identified 21 rRNA genes and 76 tRNA genes. In addition, 17 antimicrobial resistance genes spanning seven antimicrobial classes were detected (Table 1), including β-lactamase genes (blaNDM-1, blaOXA-58, and blaIMP-14), macrolide resistance genes (msr(E) and mph(E)), aminoglycoside resistance genes (aacA34, strB, strA, aadA2, aphA5a, aadB, and aac(6')-Ib4), phenicol resistance genes (floR and cmlA1), the sulfonamide resistance gene sul1, the tetracycline resistance gene tet(39), and the quinolone resistance gene qnrVC6.

TABLE 1.

Antimicrobial resistance genes identified in A. soli SLAB

Antimicrobial resistance gene Contig Identity (%) Position in contig Antimicrobial resistance category Accession no. of reference gene
bla OXA-58 pSLAB-A 100 32416–33258 Beta-lactam NG_049798.1
bla NDM-1 pSLAB-A 100 104919–105731 Beta-lactam NG_049326.1
bla IMP-14 pSLAB-A 99.86 87925–88665 Beta-lactam NG_049177.1
aacA34 pSLAB-A 100 87339–87779 Aminoglycoside NG_047319.1
strB pSLAB-A 97.61 90092–90928 Aminoglycoside NG_047464.1
strA pSLAB-A 97.7 90928–91753 Aminoglycoside NG_056002.2
aadA2 pSLAB-A 100 91761–92552 Aminoglycoside NG_051846.1
aadB pSLAB-A 100 94159–94692 Aminoglycoside NG_047387.1
aphA5a pSLAB-A 100 114300–115079 Aminoglycoside NG_047448.1
aac(6')-Ib4 pSLAB-A 100 133612–134166 Aminoglycoside NG_051844.1
floR pSLAB-A 99.92 10722–11936 Phenicol NG_051844.1
cmlA1 pSLAB-A 99.6 92645–93904 Phenicol NG_047647.1
msr(E) pSLAB-A 99.8 17445–18923 Macrolide NG_048007.1
mph(E) pSLAB-A 100 18979–19863 Macrolide NG_064660.1
sul1 pSLAB-A 100 86041–86880 Sulfonamide NG_048082.1
qnrVC6 pSLAB-A 100 134330–134986 Quinolone NG_050555.1
tet(39) pSLAB-D 100 8255–9442 Tetracycline NG_048137.1

Among the 17 antimicrobial resistance genes identified in A. soli SLAB, all except tet(39) are located on plasmid pSLAB-A (294,790 bp), including the three carbapenemase-encoding genes blaOXA-58, blaNDM-1, and blaIMP-14. Plasmid pSLAB-A is 294,790 bp in length with a GC content of 39% and harbors 300 predicted coding sequences. Its circular map is shown in Fig. 1A. Analysis using the PlasmidFinder database failed to identify any known plasmid replicon. Gene annotation revealed that most antimicrobial resistance genes on pSLAB-A are organized into a large resistance cluster. Within this cluster, blaNDM-1 and blaIMP-14 are concentrated within an approximately 40 kb region (from ~80 kb to ~120 kb). This region also contains multiple additional resistance genes, including sul1, aacA34, strB, strA, aadA2, cmlA1, aadB, and aphA5a. In contrast, blaOXA-58 is located in a relatively discrete region of the plasmid. Conjugation assays showed that plasmid pSLAB-A was not transferable to the recipient strain. Screening for conjugation-associated genes, including components of the type IV secretion system, identified none, suggesting that the absence of essential transfer-related elements likely underlies the lack of transconjugants. Notably, serial passage assays demonstrated that pSLAB-A remained highly stable, with retention rates of 100% at day 3, 97% at day 6, and 91% at day 9.

Fig 1.

Circular maps of plasmid pSLAB-A at 294,790 bp showing antimicrobial resistance genes and insertion sequences, compared with related Acinetobacter plasmids at varying sequence identity levels.

(A) Circular map of plasmid pSLAB-A from strain SLAB. Antimicrobial resistance genes are shown in red, and insertion sequences are indicated in blue. (B) Circular comparison of plasmid pSLAB-A with closely related plasmids retrieved from the NCBI database: pAS336-1 (A. soli, CP119218.1, 272,687 bp), pAS435-1 (A. soli, CP119229.1, 296,393 bp), pAS645-1 (A. soli, CP119239.1, 299,645 bp), pAS967-1-1 (A. soli, CP119216.1, 324,273 bp), pAS566-1 (A. soli, CP119251.1, 325,311 bp), pAS843-1 (A. soli, CP119204.1, 324,240 bp), pAS903-1-1 (A. soli, CP119208.1, 317,471 bp), and pAP43-OXA58-NDM1 (A. pittii, CP043053.1https://www.ncbi.nlm.nih.gov/nuccore/CP043053.1/, 268,263 bp).

We further analyzed the genetic environments surrounding the three carbapenemase-encoding genes. The blaNDM-1 gene was found to be located within a conserved 10,038 bp segment flanked by two ISAba125 insertion sequences, forming the composite transposon Tn125 with the structure “ISAba125 - blaNDM-1 - bleMBL - trpF - dsbD - cutA - groES - groL - insE - ISAba125” (Fig. 2A and B). This genetic structure showed complete sequence conservation (100% coverage and 100% identity) with corresponding regions identified in Acinetobacter spp. genomes with accession numbers JN377410.2 and CP014478.1 (Fig. 2B). Comparative analysis with related plasmids retrieved from the NCBI database, including pAS903-1-1 (accession numbers CP119208.1) and pAS967-1-1 (accession number CP119216.1), suggested that the blaNDM-1-containing region in plasmid pSLAB-A was likely acquired through ISAba125-mediated transposition (Fig. 2A).

Fig 2.

Genomic maps comparing plasmids pSLAB-A, pAS903-1-1, and pAS967-1-1 show conserved resistance gene contexts for blaNDM-1, blaIMP integrons, and blaOXA-58 regions across Acinetobacter species.

(A) Comparative analysis of plasmids pAS903-1-1, pAS967-1-1, and pSLAB-A. Antimicrobial resistance genes are shown in red, and insertion sequences are indicated in purple. (B) Comparative analysis of the blaNDM-1 genetic context. Shaded regions represent sequence homology across corresponding loci on different plasmids. Arrows indicate gene length and orientation and are labeled with gene names; blaNDM-1 is highlighted in red, and ISAba125 is shown in purple. (C) Schematic representation of distinct class 1 integrons carrying the blaIMP gene in Acinetobacter spp. Arrows indicate the direction of gene transcription. The 5′ conserved segment (5′-CS) and 3′ conserved segment (3′-CS) are highlighted in orange, while the variable region is shown in light orange. The blaIMP gene is displayed in red. (D) Structural comparison of blaOXA-58–harboring regions among plasmids pAP43-OXA58-NDM1, W76_pNDM, AB0614_pNDM, and pSLAB-A. Green arrows indicate ISAba3, the blaOXA-58 gene is shown in red, and purple arrows represent ISAba125.

The blaIMP-14 gene is embedded within a canonical class 1 integron comprising a 5′ conserved segment (intI1), a variable gene cassette array containing blaIMP-14 and additional antimicrobial resistance genes, and a 3′ conserved segment (qacEΔ1–sul1; Fig. 2C). This integron architecture represents a highly efficient genetic platform for the horizontal dissemination of blaIMP-14 among Acinetobacter lineages (25).

The blaOXA-58 gene is classically bracketed by two ISAba3 elements. In plasmid pSLAB-A, however, the upstream ISAba3 is truncated by insertion of ISAba125, whereas the downstream ISAba3 remains intact (Fig. 2D). This rearrangement is functionally significant, as ISAba125 provides a strong outward-facing promoter that drives overexpression of blaOXA-58, thereby markedly enhancing carbapenem resistance, as previously demonstrated (26).

Using pSLAB-A as the reference, BLASTn searches were performed against the NCBI database with thresholds of >99% nucleotide identity and ≥70% query coverage, yielding eight closely related plasmids (Table S2): pAS336-1 (CP119218.1), pAS435-1 (CP119229.1), pAS645-1 (CP119239.1), pAS967-1-1 (CP119216.1), pAS566-1 (CP119251.1), pAS843-1 (CP119204.1), pAS903-1-1 (CP119208.1), and pAP43-OXA58-NDM1 (CP043053.1). Among these, pAP43-OXA58-NDM1 originated from Acinetobacter pittii, whereas all remaining plasmids were recovered from A. soli. The plasmid showing the highest similarity to pSLAB-A was pAS336-1 (99.79% identity and 82% coverage), which was isolated from A. soli strain AS336 recovered from a bloodstream infection in Taiwan, China, in 2001. A concentric circular comparison of pSLAB-A with these homologous plasmids is shown in Fig. 1B. Notably, eight plasmids in our data set could not be assigned to any APT Rep type (Table S4), consistent with previous reports that plasmids lacking known Rep sequences are associated with the dissemination of important antimicrobial resistance genes (22). This analysis revealed a highly conserved plasmid backbone shared across all plasmids, with a notable exception in pSLAB-A: a unique resistance-enriched region of approximately 40 kb (from 80 kb to 120 kb) that harbors blaNDM-1, blaIMP-14, and eight additional antimicrobial resistance genes.

A global search of the NCBI database identified 15 A. soli strains carrying carbapenemase-encoding genes (Table S3). Except for one isolate from Thailand, all others originated from China, including Taiwan (n = 7), Zhejiang (n = 6), and Guangdong (n = 1). Across these isolates, seven distinct carbapenemases were detected: blaOXA-164, blaOXA-58, blaOXA-72, blaNDM-1, blaIMP-1, blaIMP-14, and blaVIM-11 (Fig. 3). blaNDM-1 was the most prevalent (46.7%, 7/15), followed by blaIMP-1 (33.3%, 5/15), blaOXA-164 (20.0%, 3/15), blaOXA-58 (20.0%, 3/15), blaVIM-11 (13.3%, 2/15), blaOXA-72 (6.7%, 1/15), and blaIMP-14 (6.7%, 1/15). Nine isolates carried a single carbapenemase gene, five carried two, whereas only strain SLAB co-harbored three carbapenemases. Among the 15 isolates, one originated from livestock, one from the environment, and the remaining 13 from clinical specimens, predominantly bloodstream infections (7/15, 46.7%). Complete genome sequences were available for eight isolates, all of which harbored their carbapenemase-encoding genes on plasmids. Phylogenetic analysis (Fig. 3) revealed that strain SLAB clustered with strains R52 and SZL7 within the same clonal lineage, differing by 59 and 62 SNPs, respectively (Fig. S1). Notably, R52 and SZL7 were isolated from clinical specimens collected in 2018 and 2023 from two independent hospitals in Zhejiang Province, indicating regional dissemination of this lineage. In addition, seven A. soli isolates were recovered from a single hospital in Taiwan over a 6-year period (2001–2007). Among these, three isolates (AS843, AS903-1, and AS967-1), collected between 2006 and 2007, formed a tight clonal cluster with ≤35 SNP differences, strongly suggesting nosocomial clonal transmission within the hospital.

Fig 3.

Phylogenetic tree of 15 A. soli strains paired with a heatmap of resistance genes. SLAB carries the most genes, including blaIMP-14 and aadB. Strains span 2001 to 2023, with carbapenemase genes widely distributed.

Phylogenetic analysis of strain SLAB and 14 additional A. soli strains carrying carbapenemase-encoding genes retrieved from the NCBI database. Colored cells indicate the presence of specific antimicrobial resistance genes, whereas blank cells denote their absence. Resistance genes are grouped and annotated at the top of the figure. Sampling dates are color coded. Branch labels correspond to strain names, and the scale bar represents SNP divergence among strains.

Collectively, this study provides the first report of A. soli co-harboring three carbapenemase-encoding genes (blaNDM-1, blaOXA-58, and blaIMP-14) on a single plasmid in an ICU setting. The mobilization and accumulation of these carbapenemase-encoding genes are mediated by ISAba125, ISAba3, and class 1 integrons, underscoring their pivotal roles in inter- and intraplasmid dissemination. Global genomic evidence further indicates that the emergence and spread of carbapenem resistance in A. soli is primarily driven by the acquisition of multidrug-resistance plasmids, which can fuel clonal expansion within hospital environments. These data underscore that plasmids play a central role in disseminating and accumulating antimicrobial resistance within this species. The propagation of such high-risk plasmids in A. soli poses a serious threat to antimicrobial therapy and represents an escalating challenge for infection control in intensive care units.

ACKNOWLEDGMENTS

This work was supported by the National Natural Science Foundation of China (No. 82172314), the Zhejiang Provincial Disease Control and Prevention Science and Technology plan (No. 2026JKY124), Ningbo Natural Science Foundation (Nos. 202003N4221 and 2021J271), and Ningbo Top Medical and Health Research Program (No. 2023020713).

Fang He: Funding acquisition; study design. Wenping Lin: Funding acquisition; final approval of the manuscript. Qiao Li: Data acquisition; drafting of the manuscript. Nanqi Zhang and Hao Guo: Software; visualization. Juan Xu and Andrey Bakunovich: Data analysis.

Contributor Information

Wenping Lin, Email: linwenping2018@163.com.

Fang He, Email: hetrue@163.com.

Mehrad Hamidian, University of Technology Sydney, Sydney, Australia.

ETHICS APPROVAL

This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Zhejiang Provincial People’s Hospital (Ethics approval number 2019KY244). In this case, the Ethics Committee of Zhejiang Provincial People’s Hospital granted an exemption from written informed consent because our study focused solely on bacteria. The clinical isolates were collected as part of the routine hospital laboratory procedures.

DATA AVAILABILITY

The whole-genome results of strain SLAB have been deposited in DDBJ/EMBL/GenBank under accession numbers JBRAZX010000001–JBRAZX010000007.

SUPPLEMENTAL MATERIAL

The following material is available online at https://doi.org/10.1128/spectrum.01130-26.

Supplemental figure and tables. spectrum.01130-26-s0001.docx.

Fig. S1 and Tables S1 to S4.

DOI: 10.1128/spectrum.01130-26.SuF1

ASM does not own the copyrights to Supplemental Material that may be linked to, or accessed through, an article. The authors have granted ASM a non-exclusive, world-wide license to publish the Supplemental Material files. Please contact the corresponding author directly for reuse.

REFERENCES

  • 1. Truszkowska E, Czyżewski K, Derwich K, Jaremek K, Grochowska O, Zalas-Więcek P, Pawińska-Wąsikowska K, Czogała W, Skoczeń S, Balwierz W, et al. 2025. Clinical analysis of Acinetobacter species infections in children and adolescents treated for cancer or undergoing hematopoietic cell transplantation: a multicenter nationwide study. J Clin Med 14:4928. doi: 10.3390/jcm14144928 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Liu Z, Cai H, Lei J, Zhang X, Yin J, Zhang Y, Yu X, Geng Y. 2025. Distribution and analysis of the resistance profiles of bacteria isolated from blood cultures in the intensive care unit. Front Microbiol 16:1464573. doi: 10.3389/fmicb.2025.1464573 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Cao JG, Zhang H, Xu YP, Yan ZQ, Liu YX. 2015. First report of carbapenem-resistant Acinetobacter soli isolates coharboring blaNDM-1 and blaOXA-58 genes from China. Diagn Microbiol Infect Dis 83:407–408. doi: 10.1016/j.diagmicrobio.2015.08.008 [DOI] [PubMed] [Google Scholar]
  • 4. Guo H, Li L, Chen Y, He F. 2023. Genomic insights into a multidrug-resistant Acinetobacter bereziniae strain co-carrying blaOXA-301 and blaNDM-1 from China. J Glob Antimicrob Resist 35:56–59. doi: 10.1016/j.jgar.2023.08.008 [DOI] [PubMed] [Google Scholar]
  • 5. Kim D, Baik KS, Kim MS, Park SC, Kim SS, Rhee MS, Kwak YS, Seong CN. 2008. Acinetobacter soli sp. nov., isolated from forest soil. J Microbiol 46:396–401. doi: 10.1007/s12275-008-0118-y [DOI] [PubMed] [Google Scholar]
  • 6. Pellegrino FLPC, Vieira VV, Baio PVP, dos Santos RMR, dos Santos ALA, Santos NG de B, Meohas MMGL, Santos RT, de Souza TC, da Silva Dias RC, Santoro-Lopes G, Riley LW, Moreira BM. 2011. Acinetobacter soli as a cause of bloodstream infection in a neonatal intensive care unit. J Clin Microbiol 49:2283–2285. doi: 10.1128/JCM.00326-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Lauderdale TL, Hsu MC, Mu JJ, Chang FY, Lai JF, Tan MC, Wang HY, Chang SC. 2014. NDM-1-producing Acinetobacter soli from Taiwan. Diagn Microbiol Infect Dis 80:168–169. doi: 10.1016/j.diagmicrobio.2014.06.008 [DOI] [PubMed] [Google Scholar]
  • 8. Furugaito M, Anraku M, Kawahara R, Hisato A, Kamisako T, Yoshida K. 2023. First report of New Delhi metallo-β-lactamase-1-producing Acinetobacter soli in Japan. J Infect Chemother 29:1177–1180. doi: 10.1016/j.jiac.2023.07.009 [DOI] [PubMed] [Google Scholar]
  • 9. Liu L, Huang Y, Jiang Y, Wang Y, Liu K, Pei Z, Li Z, Zhu Y, Lu J, Li X. 2025. Distribution features and antimicrobial resistance trends of clinical pathogens: a retrospective study in a tertiary teaching hospital in East China (2020-2024). Infect Drug Resist 18:6889–6903. doi: 10.2147/IDR.S573970 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Nguyen M, Joshi SG. 2021. Carbapenem resistance in Acinetobacter baumannii, and their importance in hospital-acquired infections: a scientific review. J Appl Microbiol 131:2715–2738. doi: 10.1111/jam.15130 [DOI] [PubMed] [Google Scholar]
  • 11. Sati H, Carrara E, Savoldi A, Hansen P, Garlasco J, Campagnaro E, Boccia S, Castillo-Polo JA, Magrini E, Garcia-Vello P, Wool E, Gigante V, Duffy E, Cassini A, Huttner B, Pardo PR, Naghavi M, Mirzayev F, Zignol M, Cameron A, Tacconelli E, WHO Bacterial Priority Pathogens List Advisory Group . 2025. The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance. Lancet Infect Dis 25:1033–1043. doi: 10.1016/S1473-3099(25)00118-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Nordmann P, Poirel L. 2019. Epidemiology and diagnostics of carbapenem resistance in gram-negative bacteria. Clin Infect Dis 69:S521–S528. doi: 10.1093/cid/ciz824 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Baraka A, Traglia GM, Montaña S, Tolmasky ME, Ramirez MS. 2020. An Acinetobacter non-baumannii population study: antimicrobial resistance genes (ARGs). Antibiotics 10. doi: 10.3390/antibiotics10010016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Çalık Ş, Kansak N, Aksaray S. 2022. Phenotypic detection of carbapenemase production in carbapenem-resistant isolates with the rapid carbapenemase detection method (rCDM). J Microbiol Methods 200:106536. doi: 10.1016/j.mimet.2022.106536 [DOI] [PubMed] [Google Scholar]
  • 15. Petit M, Caméléna F, Cointe A, Poncin T, Merimèche M, Bonacorsi S, Birgy A, Berçot B. 2020. Rapid detection and characterization of carbapenemases in Enterobacterales with a new modified carbapenem inactivation method, mCIMplus. J Clin Microbiol 58. doi: 10.1128/JCM.01370-20 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Bortolaia V, Kaas RS, Ruppe E, Roberts MC, Schwarz S, Cattoir V, Philippon A, Allesoe RL, Rebelo AR, Florensa AF, et al. 2020. ResFinder 4.0 for predictions of phenotypes from genotypes. J Antimicrob Chemother 75:3491–3500. doi: 10.1093/jac/dkaa345 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Siguier P, Perochon J, Lestrade L, Mahillon J, Chandler M. 2006. ISfinder: the reference centre for bacterial insertion sequences. Nucleic Acids Res 34:D32–6. doi: 10.1093/nar/gkj014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Wang M, Goh YX, Tai C, Wang H, Deng Z, Ou HY. 2022. VRprofile2: detection of antibiotic resistance-associated mobilome in bacterial pathogens. Nucleic Acids Res 50:W768–W773. doi: 10.1093/nar/gkac321 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Sullivan MJ, Petty NK, Beatson SA. 2011. Easyfig: a genome comparison visualizer. Bioinformatics 27:1009–1010. doi: 10.1093/bioinformatics/btr039 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Alikhan NF, Petty NK, Ben Zakour NL, Beatson SA. 2011. BLAST Ring Image Generator (BRIG): simple prokaryote genome comparisons. BMC Genomics 12:402. doi: 10.1186/1471-2164-12-402 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Lam MMC, Koong J, Holt KE, Hall RM, Hamidian M. 2023. Detection and typing of plasmids in Acinetobacter baumannii using rep genes encoding replication initiation proteins. Microbiol Spectr 11:e0247822. doi: 10.1128/spectrum.02478-22 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Tobin LA, Lam MMC, Hamidian M. 2025. Pan-genus analysis and typing of antimicrobial resistance plasmids in Acinetobacter. NPJ Antimicrob Resist 3:65. doi: 10.1038/s44259-025-00133-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. He J, Hong L, Song M, Zhang Y, Zhang W, Zhang L, Zhou D, Chen Z, Yu Y, Chen H, Hua X. 2025. Diverse Acinetobacter species and plasmid-driven spread of carbapenem resistance in pharmaceutical settings in China. Environ Int 198:109373. doi: 10.1016/j.envint.2025.109373 [DOI] [PubMed] [Google Scholar]
  • 24. Baomo L, Lili S, Moran RA, van Schaik W, Chao Z. 2021. Temperature-regulated IncX3 plasmid characteristics and the role of plasmid-encoded H-NS in thermoregulation. Front Microbiol 12:765492. doi: 10.3389/fmicb.2021.765492 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Xu Q, Mu X, He J, Liu H, Liu X, Wang Y, Hua X, Yu Y. 2025. Phenotypic and genotypic characterization of clinical carbapenem-resistant Acinetobacter species harboring the metallo-beta-lactamases IMP-8 or NDM-1 in China. Microbiol Spectr 13:e0115824. doi: 10.1128/spectrum.01158-24 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Chen FJ, Huang WC, Liao YC, Wang HY, Lai JF, Kuo SC, Lauderdale TL, Sytwu HK. 2019. Molecular epidemiology of emerging carbapenem resistance in Acinetobacter nosocomialis and Acinetobacter pittii in Taiwan, 2010 to 2014. Antimicrob Agents Chemother 63:e02007-18. doi: 10.1128/AAC.02007-18 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental figure and tables. spectrum.01130-26-s0001.docx.

Fig. S1 and Tables S1 to S4.

DOI: 10.1128/spectrum.01130-26.SuF1

Data Availability Statement

The whole-genome results of strain SLAB have been deposited in DDBJ/EMBL/GenBank under accession numbers JBRAZX010000001–JBRAZX010000007.


Articles from Microbiology Spectrum are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES